Mar 16, 2022 / 02:15PM GMT
Peter Richard Lawson - Barclays Bank PLC, Research Division - Research Analyst
Great. Thank you so much. It's a pleasure to have Karyopharm up on stage with It's a pleasure to be back to in-person events. So I wanted to thank everyone for attending and enthusiasm and all your time at the conference. It's impressive to see things turn back 2 years since the last time we've done this conference and for many, it's the first in a couple of years that I want to thank everyone very much.
On that, my name is Peter Lawson. I'm one of the biotech analyst at Barclays. I'm the moderator for Karyopharm. I just want to thank, so we've got Richard Paulson, CEO from Karyopharm; Mike Mason, CFO; and we've also got Patricia Judson, Head of Medical Affairs (sic) [Strategy]
Patricia Judson - Karyopharm Therapeutics Inc. - SVP of Medical Strategy
Strategy.
Peter Richard Lawson - Barclays Bank PLC, Research Division - Research Analyst
Strategy. Sorry I can't read my own writing.
Patricia Judson -
Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers